Our work suggested that LUAD cancer progression could be initiated by progressive downregulation of tissue-specific marker genes such as SFTPC, and upregulation of stem cell signaling factors such as CD44. AT2-like cells strongly express ribosomal and mitochondrial genes that promote tumor progression. Here, SFTPC is linked to neoplasm.